Entrada Therapeutics, Inc. ($TRDA)
WENTWORTH KORY JAMES โ Chief Financial Officer
Shares
7,988
Price
$12.25
Total Value
$97,892.14
Nearby Earnings
Feb 26, 2026
EPS:Est: -1.32
Revenue:Est: $7.41M
Transaction Details
| Insider | WENTWORTH KORY JAMES |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 4, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 6, 2026 |
| Shares Sold | 7,988 |
| Price per Share | $12.25 |
| Total Value | $97,892.14 |
| Shares Owned After | 137,987 |
| Derivative | No |
| Accession Number | 0001725663-26-000002 |
| Document | View SEC Filing |